Vytorin and Linagliptin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vytorin (ezetimibe; simvastatin) and Linagliptin (linagliptin). Common drug interactions include back pain among females and enterocolitis among males.

The phase IV clinical study analyzes what interactions people have when they take Vytorin and Linagliptin. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Vytorin?

Vytorin has active ingredients of ezetimibe; simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 20,084 Vytorin users. Check the latest studies of Vytorin.

What is Linagliptin?

Linagliptin has active ingredients of linagliptin. eHealthMe is studying from 8,112 Linagliptin users. Check the latest studies of Linagliptin.

On Jul, 11, 2026

11 people who take Vytorin and Linagliptin together, and have interactions are studied.

Vytorin and Linagliptin drug interactions.

What are the common drug interactions of Vytorin and Linagliptin, by gender? *:

female:

Back pain

male:

Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Acute myocardial infarction (acute heart attack)
Gastritis (inflammation of stomach)
Iron deficiency anaemia
Pulmonary mass
Renal failure (kidney dysfunction)
Subdural haematoma (blood collects between the skull and the surface of the brain)
Syncope (loss of consciousness with an inability to maintain postural tone)
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
Asthenia (weakness)

What are the common drug interactions of Vytorin and Linagliptin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Acute myocardial infarction (acute heart attack)
Chlamydial infection (a common sexually transmitted infection (sti) in humans caused by the bacterium chlamydia trachomatis)
Gastritis (inflammation of stomach)
Iron deficiency anaemia

60+:

Asthenia (weakness)
Back pain
Subdural haematoma (blood collects between the skull and the surface of the brain)
Syncope (loss of consciousness with an inability to maintain postural tone)
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
Balance disorder
Chronic kidney disease
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Constipation
Faecaloma (hard mass of fecal matter)

What are the existing conditions these people have? *

Diabetes: 6 people, 54.55%
High Blood Pressure: 6 people, 54.55%
Chronic Kidney Disease: 5 people, 45.45%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 36.36%
Type 2 Diabetes: 3 people, 27.27%
Pain: 2 people, 18.18%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 2 people, 18.18%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 2 people, 18.18%
Hyperkalemia (damage to or disease of the kidney): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Vytorin and Linagliptin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously